La Maison de l'Artemisia

What La Maison de l'Artemisia does

La Maison de l'Artemisia is a Paris-based nonprofit association (association loi 1901) founded in 2013 that operates a global humanitarian network promoting the use of Artemisia annua and Artemisia afra plants to treat malaria, bilharzia (schistosomiasis), tuberculosis, and other parasitic diseases. The association runs 153 multidisciplinary Artemisia Houses across 27 countries, supported by a research network linking universities and scientists in both the Global North and South, and serves as the coordination hub for local cultivation, processing, and distribution activities. Editorial operations are managed by Lucile Cornet-Vernet from the headquarters at 20 rue Pierre Demours, 75017 Paris.

The organization's core offerings include standardized whole-plant Artemisia products — herbal tea (tisane), powder, Artemiel (Artemisia blended with honey for pediatric administration), and an Artemisia-based biospray biopesticide developed with the Aga Khan Foundation. Under the One Health framework spanning human, animal, and environmental health, the network also delivers cultivation training programs, micro-business support for smallholder farmers, and mosquito-repellent hedge plantings. Scientific credibility is reinforced through research partnerships with Université Paris-Saclay, Sorbonne Université / INSERM, IRD, and Institut Pasteur Bangui, alongside a historic 2025 publication in JAMA and a 2025 Le Monde op-ed for World Malaria Day.

The revenue model is donation-based, with no commercial pricing or sales reported. Treatments, training, and starter materials are provided free or at cost to disadvantaged populations through Artemisia Houses, while operating funds are sourced from individual donors, family foundations (Fondation JB Poylo, Fondation Haller, Fondation OSH, Fondation Lemarchand, Fondation AnBer, Fond des Celestins), and institutional partners (Impala Avenir). Reach is significant in social terms — more than 10 million beneficiaries since 2013 — but organizational scale remains small, with 14 employees based primarily in Paris and a distributed network of local teams in each Artemisia House.

Name

La Maison de l'Artemisia

Legal name

LA MAISON DE L'ARTEMISIA

Website

https://maison-artemisia.org

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

La Maison de l'Artemisia is a Paris-based nonprofit founded in 2013 that operates 153 Artemisia Houses across 27 countries, promoting whole-plant Artemisia annua and afra herbal treatments for malaria, bilharzia, and other diseases through local cultivation, training, and community health programs.

Ownership category

akta.pro rank

Product category

Traditional Herbal Medicine and Humanitarian Health Services

NAICS

Support Activities for Crop Production (11511), Farm Management Services (115116), Voluntary Health Organizations (813212)

SIC

Medicinal Chemicals & Botanical Products (2833), Agricultural Services (700), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)

akta.pro secondary industries

Organic Herb, Spice & Medicinal/Aromatic Plant Farming (AFAGAKAE), International & Local Implementing NGOs (HLAJAKAD), Botanical Biopesticides & Plant Extracts (Essential Oils, Neem, Pyrethrins) (AFABAEAF)

Keywords

• Herbal malaria treatment
• Medicinal plant network
• Artemisia cultivation training
• Humanitarian health association
• Parasitic disease therapy

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Donations and Charitable Contributions: La Maison de l'Artemisia is a humanitarian association relying primarily on donations from individuals, foundations, and organizations. The organization does not appear to sell products commercially but provides Artemisia treatments and training free or at cost to disadvantaged populations through its network of Artemisia Houses.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels10 records

Core offering

La Maison de l'Artemisia is a French humanitarian association that promotes the use of Artemisia annua and Artemisia afra medicinal plants for the treatment of malaria, bilharzia (schistosomiasis), and tuberculosis through a global network of 153 Artemisia Houses across 27 countries. Its offerings include standardized Artemisia herbal tea (tisane), powder, and Artemiel (Artemisia mixed with honey) for human treatment, plus Artemisia biospray (biopesticide) for agricultural use, delivered alongside agronomic cultivation training and community health education under the One Health initiative.

Product overview

La Maison de l'Artemisia is a global humanitarian network offering Artemisia-based therapeutic products and services centered on Artemisia annua and Artemisia afra plants. The core product portfolio includes Artemisia herbal tea (tisane) and powder formulations for treating malaria and bilharzia, complemented by derivative products like Artemisia biospray (biopesticide) and Artemiel (Artemisia-honey mixture). The organization operates through a network of 153 Artemisia Houses across 27 countries, providing cultivation training, agronomic support, and community healthcare services under the One Health initiative.

Differentiator

Problem solved

Functional benefit

Products and services

• Artemisia Herbal Tea (Tisane)

Quantifiable outcome

• 10,000,000+ beneficiaries treated since 2013
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

14 partnerships are on record, tiered core and minor.

• Aga Khan University (AKU)coreStrategic or Co-development Partner · 1 October 2025Co-organizer of the First International Symposium on Artemisia 2025 in Arusha, Tanzania. The symposium was held at AKU's facilities and included field demonstrations at ACER (Aga Khan University Centre for Excellence in Renewable Energy and Agriculture).
• International Society for Horticultural Science (ISHS)coreStrategic or Co-development Partner · 1 October 2025Co-organizer of the First International Symposium on Artemisia 2025. ISHS is the leading scientific organization for horticultural science, providing academic credibility and international reach for the symposium.
• Aga Khan FoundationcoreStrategic or Co-development PartnerPartnership with Aga Khan Foundation in Kenya to develop and distribute Artemisia biospray - a phytosanitary treatment based on Artemisia annua and afra as biopesticide for small-scale producers. The foundation supports making the treatment accessible without impacting producer health while enabling autonomy.
• Institut Pasteur in BanguicoreStrategic or Co-development PartnerThe Institut Pasteur in Bangui welcomed La Maison de l'Artemisia, indicating a research partnership for Artemisia studies in the Central African region.
• Carbone 4minorOthersIndependent climate strategy consulting firm that evaluated the carbon footprint of local Artemisia-based treatment at 88% lower than ACTs. Provided third-party validation of environmental benefits.
• Mlango Farm / Mlango Farm FoundationcoreStrategic or Co-development PartnerKenyan-Dutch permaculture farm (created 2007) hosting the Nairobi House of Artemisia since 2020. A 70-person team cultivates 12+ acres of organic produce. Mlango Farm Foundation provides educational programs. The farm serves as a model permaculture site for the Artemisia network.
• Namelok Farm AssociationcoreStrategic or Co-development PartnerAssociation created to support the Maasai community of Naikarra (Narok West, Kenya). Hosts the Namelok House of Artemisia established in 2022, developing Artemisia cultivation with hedges for mosquito repellent and broader community health programs.
• ApiflordevcoreStrategic or Co-development PartnerAssociation supporting the Migori House of Artemisia in Kenya by financing the honey processing unit for Artemiel production (Artemisia mixed with honey), addressing children's difficulty with bitter medicines.
• Alexandre Maciuk (Universite Paris-Saclay)minorOthersAssociate Professor at the Faculty of Pharmacy, Universite Paris-Saclay. Published research on natural products in Artemisia annua and afra that could lead to new antimalarial compounds. Part of the research network supporting La Maison de l'Artemisia.
• Dominique Mazier (Sorbonne Universite / INSERM)minorOthersEmerita Professor at the Faculty of Medicine, Sorbonne University, and former Head of Parasitology/Mycology at Pitie-Salpetriere Hospital. Director of three INSERM research units. Contributed to bibliographical review published in Natural Product Reports.
• Romain Duval (IRD)minorOthersResearcher at IRD (Institut de Recherche pour le Developpement) and co-leader of MEDS team at the Faculty of Pharmacy, Universite Paris Cite. Part of research network working on Artemisia natural products.
• Core Health and Wealth InternationalminorChannel Partner/ Reseller/ DistributorKenyan community organization hosting the Tongaren House of Artemisia. Mission to improve health and wealth of communities through capacity building and development models.
• GAASPP (Golden Aged and Albinism Support and Protection Programme)minorChannel Partner/ Reseller/ DistributorCommunity-based organization in Webuye (Bungoma County, Kenya) supporting marginalized people with albinism and elderly community members. Hosts the Webuye House of Artemisia.
• Multiplant International Medicinal ConservationminorChannel Partner/ Reseller/ DistributorNon-profit organization for conservation of medicinal and aromatic plants. Consultant Joannes Samikiwo established the Kitale House of Artemisia on Kaa-Moss farm in 2019.

Scale indicators5 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Partners in Health: A globally-recognized healthcare NGO delivering services to the world's most vulnerable populations across multiple countries. Comparable in mission and operating model (international nonprofit network delivering healthcare to underserved populations), though broader in disease scope than Artemisia-focused programs.
• Médecins Sans Frontières (MSF): MSF operates field-level medical humanitarian programs in malaria-endemic regions, including direct patient treatment and supply chain management in fragile contexts. Comparable as a large international humanitarian health NGO that treats malaria patients in many of the same countries as La Maison de l'Artemisia.
• The Global Fund to Fight AIDS, Tuberculosis and Malaria: The Global Fund is the dominant multilateral financing mechanism for malaria programs in low-income countries, including ACT procurement. Operates in the same disease and beneficiary geographies as La Maison de l'Artemisia, but as a funder rather than an implementing network, and endorses conventional ACTs over whole-plant Artemisia.
• Malaria Consortium: A UK-based nonprofit focused on prevention, diagnosis, and treatment of malaria and other communicable diseases, operating as an implementing organization across Africa and Asia. Directly comparable as a multinational humanitarian malaria NGO with field operations, donor-funded model, and similar target populations.
• WHO Global Malaria Programme: The WHO's Global Malaria Programme sets international policy, treatment guidelines, and funding frameworks for malaria, including the recommendation against Artemisia herbal tea that La Maison de l'Artemisia explicitly defers to on its website. Operates broadly in the same disease and geography but is a multilaterally-funded global regulator rather than an implementing NGO.
• Medicines for Malaria Venture (MMV): MMV is a Swiss-based product development partnership focused on discovering, developing, and delivering new antimalarial medicines, including artemisinin-based therapies. Comparable as a malaria-focused organization with a global footprint and scientific mission, though it pursues pharmaceutical drug development rather than whole-plant herbal approaches.

Emerging players

• Botanic Healthcare: An Indian botanical extracts and natural ingredients company producing standardized plant extracts including Artemisia-derived ingredients for pharmaceutical and nutraceutical markets. Comparable in operating layer (Artemisia plant-based products) but commercially oriented versus La Maison de l'Artemisia's humanitarian nonprofit model.

Regional players

• Rwanda Biomedical Centre / Rwanda Ministry of Health Malaria Programme: National malaria control programs in East African countries operate as government-led implementers of malaria prevention, diagnosis, and treatment strategies that include community health worker distribution networks parallel to La Maison de l'Artemisia's Artemisia Houses. Comparable in operating model and geography, but state-led rather than nonprofit.

Direct peers

• ANAMED International (Action for Natural Medicine): ANAMED is a German-headquartered nonprofit that promotes the cultivation and use of Artemisia annua (and other medicinal plants) for malaria treatment in tropical countries. Directly comparable to La Maison de l'Artemisia on mission, product approach (whole-plant herbal therapy), nonprofit structure, and target beneficiaries across Africa and Asia.

Others

• Vector Control / Liverpool School of Tropical Medicine: An academic research institution engaged in malaria and neglected tropical disease research globally, often publishing peer-reviewed evidence on Artemisia and alternative therapies. Comparable as a research partner / scientific authority that validates or contests whole-plant Artemisia claims, with overlap via research scientists (e.g., Dominique Mazier) named in the data.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/ArtemisiaMaison
• YouTubeyoutube.com/channel/UCkYieGm9fY0472lMBkxmy3A
• Facebookfacebook.com/La-Maison-de-lArtemisia-1918098071783031
• LinkedInlinkedin.com/company/la-maison-de-l'artemisia
• Instagraminstagram.com/lamaisondelartemisia

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about La Maison de l'Artemisia